carrot carrot carrot Change Centers x cognizanti collaborators create-folder Data Science Decisive Infrastructure download download edit Email exit Facebook files folders future-of-work global sourcing industry info infographic linkedin location Mass Empowerment Mobile First our-latest-thinking pdf question-mark icon_rss save-article search-article search-folders settings icon_share smart-search Smart Sourcing icon_star Twitter Value Webs Virtual Capital workplace Artboard 1

Please visit the COVID-19 response page for resources and advice on managing through the crisis today and beyond.


Cognizant Shared Investigator Platform

Cognizant Shared Investigator Platform

Roche cuts its global feasibility process by 36% with Cognizant SIP

A standardized feasibility process powered by Cognizant® Shared Investigator Platform (SIP) drives efficiencies while improving the user experience for both site and sponsor teams.

Learn more

A new way forward

In light of the pandemic and technology breakthroughs such as AI and remote collaboration, life sciences organizations around the world are reconsidering how they conduct clinical trials.
Cognizant’s Shared Investigator Platform supports a new approach for streamlining clinical trials. As the industry’s first open, SaaS-based clinical ecosystem, Cognizant SIP connects sponsors, sites and technology providers working at home or other locations. It does so all from one place, with one sign-in.
Many leading life sciences companies have joined SIP, committing to a shared vision of common workflows, training and documents. Sponsors and sites report improved efficiencies and quicker study start-ups. The result? Faster time to market for new therapies—and more time helping patients.
Learn more about our Life Sciences solutions for your business.

Recently published insights

Today's new normal
Today's new normal

Cognizant SIP for COVID-19

Read ebook Read ebook
Agile drug development
Agile drug development

The new urgency required

Read ebook Read ebook

Related thinking

Reinventing clinical trials for a stay-at-home world

As current social distancing guidelines prevent most face-to-face clinical trials, now’s the time to move to decentralized clinical trials.

Accelerating clinical trials: The new and future normal

Keeping clinical trials operating efficiently during the COVID-19 pandemic is forcing the life sciences industry to adopt new working practices.



Avi Kulkarni

SVP Life Sciences Strategic Business Unit

Kavitha Lokesh

VP, Head of LS R&D Delivery and Products and Platforms

Om Prakash

AVP Life Sciences, Head of Shared Investigator Platform

Vishal Janani

Product Manager, Cognizant Shared Investigator Platform

Lestter Cruz Serrano

Head of Medical Affairs, Shared Investigator Platform

Take the first step

Serving customers by looking forward as well as back is a big promise, but the power of today’s new digital capabilities is vast and growing.

Let’s talk about how digital can work for your business.

We'd like your feedback to help improve the website.

Give feedback No, thank you